Fatty Acid Metabolism Characteristics in Clonorchis sinensis Related Intrahepatic Cholangiocarcinoma

Fatty Acid Metabolism Characteristics in Clonorchis sinensis Related Intrahepatic Cholangiocarcinoma

Intrahepatic cholangiocarcinoma (ICC) is a malignant tumor originating from the epithelial cells of the secondary and higher bile ducts, and it is the second most common primary liver cancer. In recent years, the incidence and mortality rates of ICC have been rising globally. Clonorchis sinensis (referred to as “liver fluke”) has been classified as a … Read more

Overview of Diagnosis and Staging of Primary Liver Cancer

Overview of Diagnosis and Staging of Primary Liver Cancer

Primary liver cancer is currently the 4th most common malignant tumor in China and the 2nd leading cause of cancer-related death, posing a serious threat to the lives and health of the Chinese people. Primary liver cancer mainly includes three different pathological types: hepatocellular carcinoma (hepatocellular carcinoma, HCC), intrahepatic cholangiocarcinoma (intrahepatic cholangiocarcinoma, ICC), and combined … Read more

Imaging Diagnosis of Intrahepatic Cholangiocarcinoma

Imaging Diagnosis of Intrahepatic Cholangiocarcinoma

Click the “Chinese Journal of Practical Surgery” above to subscribe! Professor Zhou Weiping [Cite This Article] Gu Fangming, Zhou Weiping. Imaging Diagnosis of Intrahepatic Cholangiocarcinoma [J]. Chinese Journal of Practical Surgery, 2020, 40(6): 738-740. Imaging Diagnosis of Intrahepatic Cholangiocarcinoma Gu Fangming, Zhou Weiping Chinese Journal of Practical Surgery, 2020, 40(6): 738-740 Abstract The rapid development … Read more

Systemic Treatment for Advanced Intrahepatic Cholangiocarcinoma (ICC)

Systemic Treatment for Advanced Intrahepatic Cholangiocarcinoma (ICC)

Intrahepatic cholangiocarcinoma (ICC) originates from the epithelial cells of the intrahepatic bile ducts. Among primary liver malignancies, the incidence of ICC is second only to hepatocellular carcinoma, accounting for 10% to 15% of primary liver cancer. Recommended Suggestions 1) It is recommended to use a combination regimen of gemcitabine and platinum-based drugs, and if conditions … Read more

Comprehensive Surgical Treatment of Intrahepatic Cholangiocarcinoma

Comprehensive Surgical Treatment of Intrahepatic Cholangiocarcinoma

Intrahepatic cholangiocarcinoma (ICC) accounts for approximately 10% to 15% of primary liver cancers, and its incidence has been on the rise globally in recent years. The causes and risk factors for ICC are complex, with established risk factors including age, intrahepatic bile duct stones, liver fluke disease, bile duct adenoma, bile duct papillomatosis, bile duct … Read more

Local Treatment and Evaluation of Intrahepatic Cholangiocarcinoma

Local Treatment and Evaluation of Intrahepatic Cholangiocarcinoma

Click on the “Chinese Practical Surgery Magazine” above to subscribe! Professor Chen Minshan [Cite This Article] Chen Minshan, Fu Yizhen. Local Treatment and Evaluation of Intrahepatic Cholangiocarcinoma[J]. Chinese Practical Surgery Magazine, 2020, 40(6):684-688. Local Treatment and Evaluation of Intrahepatic Cholangiocarcinoma Chen Minshan, Fu Yizhen Chinese Practical Surgery Magazine, 2020, 40(6):684-688 Abstract Intrahepatic cholangiocarcinoma (ICC) is … Read more

Neoadjuvant and Adjuvant Therapy for Intrahepatic Cholangiocarcinoma

Neoadjuvant and Adjuvant Therapy for Intrahepatic Cholangiocarcinoma

Authors: Lin Yuxuan, Xia Yong, Shen Feng Source: Chinese Journal of Hepatobiliary Surgery, 2023, 29(7) Abstract Intrahepatic cholangiocarcinoma (ICC) is a type of adenocarcinoma originating from the intrahepatic secondary bile ducts and their branches, characterized by high malignancy and poor prognosis. Radical surgical resection is currently the only potentially curative treatment for ICC, but only … Read more

Challenging Intrahepatic Cholangiocarcinoma: Irreversible Electroporation Assists in Breaking the Deadlock

Challenging Intrahepatic Cholangiocarcinoma: Irreversible Electroporation Assists in Breaking the Deadlock

Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer after hepatocellular carcinoma, accounting for approximately 10%-15% of primary liver cancer cases, and is rightly termed the “second-in-command” killer within the liver. Over the past 40 years, the incidence of ICC has been on the rise globally, particularly pronounced in Asia. ▲ Image source: … Read more